UnknownNot Applicable

The Effect of Guided Imagery and Diaphragmatic Breathing Exercise in Pregnant Women With Hyperemesis Gravidarum

180 participantsStarted 2023-04-30

Plain-language summary

Objective: The aim of the researchers is to determine the effects of guided imagery and diaphragmatic breathing exercise application on nausea, vomiting severity, and anxiety level in pregnant with hyperemesis gravidarum. Methods: This study was planned as a single-blind randomized controlled experimental study. It is planned to be conducted with 180 pregnant women to be randomized in a university hospital in Southeastern Anatolia between April 2023 and August 2023. Data will be collected using the "Descriptive Information Form", "Nausea-Vomiting Severity Assessment Test During Pregnancy" and "Pregnancy-Related Anxiety Scale-R2". Keywords: Anxiety, Hyperemesis Gravidarum, Nausea-Vomiting, Guided Imagery, Diaphragmatic Breathing Exercise, Nursing,

Who can participate

Age range19 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 19 years and over, * Being primiparous, * Able to communicate verbally, * Agreeing to participate in the study, * Able to read and write, * 12th week of pregnancy and above * At least 3 days of hospitalization, * Having a single and live fetus, * No fetal congenital malformation, * Pregnant women who do not have systemic diseases (GIS, audiovestibular, endocrine, infection, and psychological) that may cause nausea and vomiting other than nausea and vomiting caused by pregnancy will be included in the study. Exclusion Criteria: * Having a risky pregnancy diagnosis; * Obstetric complications, * Having a psychiatric diagnosis, * With systemic disease, * Having multiple pregnancies, * Fetal congenital malformation, * Pregnant women with systemic diseases that may cause nausea-vomiting will not be included in the study.

What they're measuring

Nausea-Vomiting Severity

Timeframe: 20 minutes after interventions

Trial details

NCT IDNCT05829473

SponsorGaziantep Islam Science and Technology University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-30

Contact for this trial

EMİNE KARACAN, PhD

+905300350414 emine.karacan@iste.edu.tr